Major Distribution Agreement Secured By Health Tech Company For Cancer Treatment

Precipio and Cardinal Health Ink Pioneering Distribution Agreement for HemeScreen® Cancer Molecular Assays Portfolio.

Disclaimer: This post includes affiliate links. If you purchase anything through these affiliated links, the author/website may earn a commission.

In an unprecedented move in the medical field, Precipio Inc. and Cardinal Health, two prominent entities in healthcare technology and services, have entered into a distribution agreement for the HemeScreen® po…